Back to Journals » Clinical Pharmacology: Advances and Applications » Volume 10

Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin

Total article views   HTML views PDF downloads Totals
7,671 Dovepress* 6,944+ 1,150 8,094
PubMed Central* 727 196 923
Totals 7,671 1,346 9,017
*Since 26 September 2018
Total mentioned Facebook Delicious Reddit Twitter Others
11 1 0 0 4 6

View citations on PubMed and Google Scholar